[1]刘文娟,乐世俊 姬玉洁 曹蔚 唐于平.中药多糖调节肠道菌群治疗2型糖尿病研究进展[J].陕西中医药大学学报,2023,(02):036-42.[doi:10.13424/j.cnki.jsctcm.2023.02.006 ]
　LIU Wenjuan YUE Shijun JI Yujie CAO Wei TANG Yuping.Research Progress in Treatment of Type 2 Diabetes by Regulating Intestinal Flora with Polysaccharide of Chinese Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2023,(02):036-42.[doi:10.13424/j.cnki.jsctcm.2023.02.006 ]
点击复制

中药多糖调节肠道菌群治疗2型糖尿病研究进展
分享到：

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2023年02期
页码:
036-42
栏目:
出版日期:
2023-05-13

文章信息/Info

Title:
Research Progress in Treatment of Type 2 Diabetes by Regulating Intestinal Flora with Polysaccharide of Chinese Medicine
文章编号:
2096-1340(2023)02-0036-07
作者:
刘文娟1; 2;  乐世俊1 姬玉洁1 曹蔚2 唐于平1
1.陕西中医药大学，陕西 咸阳 712046；
2.西北农林科技大学，陕西 杨凌 712100
Author(s):
LIU Wenjuan1; 2 YUE Shijun1 JI Yujie1 CAO Wei2 TANG Yuping1
1.Shaanxi University of Chinese Medicine,Shaanxi Xianyang 712046,China;
2 Northwest Agricultural and Forestry University,Shaanxi Yangling 712100,China
关键词:
关键词：中药多糖; 肠道菌群; 2型糖尿病; 胰岛素抵抗; 作用机制
Keywords:
Key words： Polysaccharides of Chinese herbal; Intestinal flora; Type 2 diabetes; Insulin resistance; Action mechanism
分类号:
R285.5
DOI:
10.13424/j.cnki.jsctcm.2023.02.006
文献标志码:
A
摘要:
摘 要：糖尿病是一种严重威胁人类健康的慢性代谢疾病，2型糖尿病（type 2 diabetes mellitus，T2DM）是最常见的糖尿病类型，其发展受到多种遗传因素和环境因素影响。肠道菌群近年来被证实是影响肥胖、T2DM等代谢疾病进程的重要因素。多项研究表明中药多糖可通过调节肠道菌群治疗T2DM。然而，T2DM患者的肠道菌群特征及中药多糖通过肠道菌群治疗T2DM的机制均尚未明确。通过综述近年来中药多糖调节肠道菌群治疗T2DM相关研究成果，为中药多糖与肠道菌群的相互作用研究提供参考，为中药多糖治疗T2DM作用机制的阐明提供理论依据。
Abstract:
Abstract： Diabetes is a chronic metabolic disease that seriously threatens human health.Type 2 diabetes (T2DM) is the most common type of diabetes,and its development is affected by a variety of genetic and environmental factors.In recent years,intestinal flora has been proved to be an important factor affecting the process of metabolic diseases such as obesity and T2DM.Many studies have shown that Chinese herbal polysaccharides can treat T2DM by regulating intestinal flora.However,the characteristics of intestinal flora in T2DM patients and the mechanism of Chinese herbal polysaccharide treating T2DM through intestinal flora are not clear.By reviewing the research results of the regulation of intestinal flora by Chinese herbal polysaccharides in the treatment of T2DM in recent years,it provides a reference for the study of the interaction between Chinese herbal polysaccharides and intestinal flora,and provides a theoretical basis for the elucidation of the mechanism of action of Chinese herbal polysaccharides in the treatment of T2DM.

参考文献/References:

[1]International Diabetes Federation IDF Diabetes Atlas te,2019［EB/OL］.（2020-07-22）［2022-11-10］.Available from https://diabetesatlas.org/en/.
[2]王庆霞.2型糖尿病的临床治疗进展[J].中国城乡企业卫生,2021,36(9):64-66.
[3]汪妮,陈梦霞,孟凡强,等.生姜多糖的提取及其对糖尿病小鼠肠道菌群的调节作用[J].食品工业科技,2022：1-16.
[4]Fei N,Zhao L.An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice［J］.Isme j,2013,7(4):880-884.
[5]刘文娟,郝晓伟,靖会,等.植物多糖的高级结构解析技术进展[J].西北药学杂志,2017,32(6):810-813.
[6]Shi X,Zhou X,Chu X,et al.Allicin Improves Metabolism in High-Fat Diet-Induced Obese Mice by Modulating the Gut Microbiota［J］.Nutrients,2019,11(12):2909.
[7]张光际,刘剑华,沈阳.四妙衍生方对高尿酸模型大鼠肠道菌群的影响[J].中国药业,2022,31(20):45-49.
[8]Qin J,Li Y,Cai Z,et al.A metagenome-wide association study of gut microbiota in type 2 diabetes.Nature［J］.2012.490(7418):55-60.
[9]Horie M,Miura T,Hirakata S,et al.Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice［J］.Experimental animals,2017,66(4):405-416.
[10]杨鑫,崔伯塔.粪菌移植在代谢性疾病中应用的研究进展[J].中华糖尿病杂志,2022,14(6):621-624.
[11]Turnbaugh PJ,Ley RE,Mahowald MA,et al.An obesity-associated gut microbiome with increased capacity for energy harvest［J］.Nature,2006,444(7122):1027-1031.
[12]逯克娜,林寒梅.肠道菌群与炎症因子参与多囊卵巢综合征的发病机制及中药干预的研究进展[J].中华中医药学刊,2022,40(3):186-190.
[13]钱映,冯月梅,汪艳姣,等.肠道菌群与慢性病关系的研究进展[J].中国微生态学杂志,2022,34(10):1217-1221.
[14]Plovier H,Everard A,Druart C,et al.A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice［J］.Nature medicine,2017,23(1):107-113.
[15]Hoffmann TW,Pham HP,Bridonneau C,et al.Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice［J］.The ISME Journal,2016,10(2):460-477.
［16］王丹萍,徐珒昭,张晓航,等.糖尿病与宿主肠道菌群的关系及饮食介导的菌群调控作用研究进展［J/OL］.食品科学:1-12［2022-11-10］.http://kns.cnki.net/kcms/detail/11.2206.TS.20221101.1533.012.html.
[17]Yoshida N,Emoto T,Yamashita T,et al.Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis［J］.Circulation,2018,138(22):2486-2498.
［18］Chelakkot C,Choi Y,Kim DK,et al.Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions［J］.Experimental & Molecular Medicine,2018,50(2):450.
［19］Camilleri,Michael.Leaky gut:mechanisms,measurement and clinical implications in humans［J］.Gut:Journal of the British Society of Gastroenterology,2019,68(8):1516-1526.
[20]戴安友.双歧三联活菌胶囊对结直肠癌术后肠道菌群及肠黏膜通透性的影响[J].中国微生态学杂志,2016，28(4):425-428.
[21]徐州玲,幸秀锦.双歧杆菌三联活菌散辅助利巴韦林颗粒对改善轮状病毒感染肠炎患儿肠道菌群与肠黏膜通透性的影响[J].抗感染药学,2021,18(7):1076-1079.
[22]Kinoshita M,Suzuki Y,Saito Y［J］.Butyrate reduces colonic paracellular permeability by enhancing PPARγ activation.Biochemical and Biophysical Research Communications，2002，293(2):827-831.
[23]Blakeney BA,Crowe MS,Mahavadi S,et al.Branched Short-Chain Fatty Acid Isovaleric Acid Causes Colonic Smooth Muscle Relaxation via cAMP/PKA Pathway［J］.Digestivediseases and sciences,2019,64(5):1171-1181.
[24]Yuille S,Reichardt N,Panda S,et al.Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid［J］.PloS one,2018,13(7):e0201073.
[25]张小芳,王欣,汪惠勤,等.人体肠道菌群代谢氨基酸产生短链脂肪酸及对细胞通透性的影响[J].中国食品学,2021,21(7):60-67.
[26]Bckhed F,Manchester JK,Semenkovich CF,et al.Mechanisms underlying the resistance to diet-induced obesity in germ-free mice［J］.Proceedings of the National Academy of Sciences of the United States of America,2007,104(3):979-984.
[27]Cani PD,Delzenne NM.The gut microbiome as therapeutic target［J］.Pharmacology & therapeutics,2011,130(2):202-212.
[28]Kim SH,Huh CS,Choi ID,et al.The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo［J］.Journal of applied microbiology,2014,117(3):834-845.
[29]Kang JH,Yun SI,Park MH,et al.Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice［J］.PloS one,2013,8(1):e54617.
[30]Miao J,Ling AV,Manthena PV,et al.Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis［J］.Nature communications,2015,6:6498.
[31]Wang G,Li X,Zhao J,et al.Lactobacillus casei CCFM419 attenuates type 2 diabetes via a gut microbiota dependent mechanism［J］.Food & function,2017,8(9):3155-3164.
[32]Elagizi A,Lavie CJ,Marshall K,et al.Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health:A Comprehensive Review［J］.Progress in Cardiovascular Diseases,2018,61(1):76-85.
[33]Khan I,Huang G,Li X,et al.Mushroom polysaccharides from Ganoderma lucidum and Poria cocos reveal prebiotic functions［J］.Journal of Functional Foods,2018,41:191-201.
[34]Cui L,Guan X,Ding W,et al.Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota［J］.International Journal of Biological Macromolecules,2021,166:1035-1045.
[35]Su A,Ma G,Xie M,et al.Characteristic of polysaccharides from Flammulina velutipes invitro digestion under salivary,simulated gastric and small intestinal conditions and fermentation by human gut microbiota［J］.International Journal of Food Science & Technology,2019:54.
[36]Zhao R,Cheng N,Nakata PA,et al.Consumption of polysaccharides from Auricularia auricular modulates the intestinal microbiota in mice［J］.Food Research International,2019,123:383-392.
[37]Wang R,Zhou G,Wang M,et al.The Metabolism of Polysaccharide from Atractylodes macrocephala Koidz and Its Effect on Intestinal Microflora［J］.Evidence-based complementary and alternative medicine,2014:926381.
[38]Metzler-Zebeli B,Zijlstra R,Mosenthin R.Dietary calcium phosphate content and oat β-glucan influence gastrointestinal microbiota,butyrate-producing bacteria and butyrate fermentation in weaned pigs［J］.FEMS microbiology ecology,2011,75:402-413.
［39］Yao Y,Yan L,Chen H,et al.Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids［J］.Phytomedicine,2020,77:153268.
［40］Fu Z,Han L,Zhang P,et al.Cistanche polysaccharides enhance echinacoside absorption in vivo and affect the gut microbiota［J］.International Journal of Biological Macromolecules,2020,149:732-740.
［41］Chang CJ,Lin CS,Lu CC,et al.Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota［J］.Nature communications,2015,6:7489.
［42］Mao Y-H,Song A-X,Li L-Q,et al.Effects of exopolysaccharide fractions with different molecular weights and compositions on fecal microflora during in vitro fermentation［J］.International Journal of Biological Macromolecules,2020,144:76-84.
［43］Xue M,Liang H,Ji X,et al.Fucoidan prevent murine autoimmune diabetes via suppression TLR4-signaling pathways,regulation DC/Treg induced immune tolerance and improving gut microecology［J］.Nutrition & metabolism,2019,16:87.
［44］Dong J,Liang Q,Niu Y,et al.Effects of Nigella sativa seed polysaccharides on type 2 diabetic mice and gut microbiota［J］.Int J Biol Macromol,2020,159: 725-738.
［45］Guo WL,Deng JC,Pan YY,et al.Hypoglycemic and hypolipidemic activities of Grifola frondosa polysaccharides and their relationships with the modulation of intestinal microflora in diabetic mice induced by high-fat diet and streptozotocin［J］.International Journal of Biological Macromolecules,2020,153:1231-1240.
［46］Liu J,Kong L,Shao M,et al.Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora［J］.Front Endocrinol (Lausanne).2022,13:1018557.
[47]Zhao X,Chen Z,Yin Y,et al.Effects of polysaccharide from Physalis alkekengi var.francheti on liver injury and intestinal microflora in type-2 diabetic mice［J］.Pharmaceutical biology,2017,55(1):2020-2025.
[48]杨宏莉,张宏馨,王燕,等.山药多糖对2型糖尿病大鼠肾病的预防作用研究[J].中国药房,2010,21(15):1345-1347.

相似文献/References:

[1]张欢　殷可婧　刘雪丽　张苗　任惠锋　周宏伟　雷变婷　秦青云.加味小建中汤对慢性心衰合并便秘患者的临床疗效观察[J].陕西中医药大学学报,2019,(06):117.[doi:10.13424/j.cnki.jsctcm.2019.06.031]
[2]陈雪莉 吕勇.基于“肠—肾轴”理论探析清肾颗粒 对慢性肾衰竭的预防作用机制[J].陕西中医药大学学报,2021,44(01):077.[doi:10.13424/j.cnki.jsctcm.2021.01.012]
[3]徐蕾 马晓燕.基于“肠-肾轴”理论治疗慢性肾脏病研究进展[J].陕西中医药大学学报,2022,(03):114.[doi:10.13424/j.cnki.jsctcm.2022.03.026]
　XU Lei MA Xiaoyan.Research Progress in Treatment of Chronic Kidney Disease Based on “Intestine-Kidney Axis” Theory[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(02):114.[doi:10.13424/j.cnki.jsctcm.2022.03.026]
[4]郑佳荟,李欢,赵重博,等.黄芩汤、葛根芩连汤对溃疡性结肠炎 小鼠肠道菌群的影响[J].陕西中医药大学学报,2023,(02):053.[doi:10.13424/j.cnki.jsctcm.2023.02.008]
　ZHENG Jiahui LI Huan ZHAO Chongbo GUO Dongyan WANG Jing.Effect of Huangqin Decoction and Gegen Qinlian Decoction onIntestinal Flora in Mice with Ulcerative Colitis[J].Journal of Shaanxi University of Traditional Chinese Medicine,2023,(02):053.[doi:10.13424/j.cnki.jsctcm.2023.02.008]
[5]高欢,王文晓 张桥 李佳佳 乐世俊.从COVID-19与肠道菌群关系探讨中医药 治疗的潜在作用机制[J].陕西中医药大学学报,2023,(02):063.[doi:10.13424/j.cnki.jsctcm.2023.02.009 ]
　GAO Huan WANG Wenxiao ZHANG Qiao LI Jiajia YUE ShijunTANG Yuping.Potential Mechanism of Chinese Medicine Treatment fromRelationship Between COVID-19 and Intestinal flora[J].Journal of Shaanxi University of Traditional Chinese Medicine,2023,(02):063.[doi:10.13424/j.cnki.jsctcm.2023.02.009 ]
[6]陈茉,赵欢 文颖娟王江 柏鲁宁.基于肠道菌群与骨骼肌关系探讨从脾论治重症肌无力的作用机制[J].陕西中医药大学学报,2023,(02):070.[doi:10.13424/j.cnki.jsctcm.2023.02.010 ]
　CHEN Mo ZHAO Huan WEN Yingjuan WANG Jiang BAI Luning.Mechanism of Treating Myasthenia Gravis fromSpleen Under Guidance of Intestinal Flora and Skeletal[J].Journal of Shaanxi University of Traditional Chinese Medicine,2023,(02):070.[doi:10.13424/j.cnki.jsctcm.2023.02.010 ]
[7]田王琪 张蔚桐 汪一凡 郭惠 王育伟.中药多糖通过调控肠道菌群干预肺癌的文献研究[J].陕西中医药大学学报,2023,(02):027.[doi:10.13424/j.cnki.jsctcm.2023.02.005 ]
　TIAN Wangqi ZHANG Weitong WANG Yifan GUO Hui WANG Yuwei TANG Yuping.Research Progress of Chinese Herbal Polysaccharides Intervening Lung Cancer by Regulating Intestinal Flora[J].Journal of Shaanxi University of Traditional Chinese Medicine,2023,(02):027.[doi:10.13424/j.cnki.jsctcm.2023.02.005 ]

备注/Memo

备注/Memo:
基金项目：国家自然科学基金项目（81974522）；陕西省自然科学基金项目（2022SF-221）
更新日期/Last Update: 2023-03-27